研究目的
To develop a smart nanoagent system for intracellular ATP-imaging and in vivo chemo-photothermal synergetic therapy with reduced side effects.
研究成果
The developed nanoagent system shows promising results for intracellular ATP-imaging and in vivo chemo-photothermal synergetic therapy with reduced side effects, presenting a new paradigm for smart and highly efficient disease treatment.
研究不足
The study focuses on the in vitro and in vivo feasibility of the nanoagent system for chemo-photothermal therapy and ATP imaging, but further clinical trials are needed to validate its efficacy and safety in humans.
1:Experimental Design and Method Selection:
The nanoagent system was prepared using DNA complex to modify gold nanoparticles (AuNPs). The DNA complex was formed by three oligonucleotides (ATP aptamer, rC-DNA and rG-DNA).
2:Sample Selection and Data Sources:
Cervical carcinoma cells (HeLa), normal liver cells (HL-7702) and breast cancer cells (MCF-7) were cultured.
3:List of Experimental Equipment and Materials:
UV-1800 ultraviolet visible spectrophotometer, RF-5301PC spectrofluorometer, JEM100CXII transmission electron microscope, Zetasizer Nano ZS, Synergy 4 microplate reader, Leica TCS SP8 confocal microscopy.
4:Experimental Procedures and Operational Workflow:
Preparation of DNA-modified AuNPs, DOX payload and release, in vitro photothermal effect evaluation, fluorescence imaging, MTT assay, in vivo synergistic chemo-photothermal therapy.
5:Data Analysis Methods:
Absorption spectra, fluorescence, TEM images, zeta potential and hydrodynamic size distribution, cytotoxicity assay, fluorescence images.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容